Segui
Mo Ebrahimkhani
Mo Ebrahimkhani
Associate professor, Department of Pathology, University of Pittsburgh
Email verificata su pitt.edu - Home page
Titolo
Citata da
Citata da
Anno
An enhanced CRISPR repressor for targeted mammalian gene regulation
NC Yeo, A Chavez, A Lance-Byrne, Y Chan, D Menn, D Milanova, ...
Nature methods 15 (8), 611-616, 2018
4352018
Cas9 gRNA engineering for genome editing, activation and repression
S Kiani, A Chavez, M Tuttle, RN Hall, R Chari, D Ter-Ovanesyan, J Qian, ...
Nature methods 12 (11), 1051-1054, 2015
3522015
CRISPR transcriptional repression devices and layered circuits in mammalian cells
S Kiani, J Beal, MR Ebrahimkhani, J Huh, RN Hall, Z Xie, Y Li, R Weiss
Nature methods 11 (7), 723-726, 2014
2372014
Stimulating healthy tissue regeneration by targeting the 5-HT2B receptor in chronic liver disease
MR Ebrahimkhani, F Oakley, LB Murphy, J Mann, A Moles, MJ Perugorria, ...
Nature medicine 17 (12), 1668-1673, 2011
2282011
Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes
SR Ferdosi, R Ewaisha, F Moghadam, S Krishna, JG Park, ...
Nature communications 10 (1), 1842, 2019
1702019
Genetically engineering self-organization of human pluripotent stem cells into a liver bud-like tissue using Gata6
P Guye, MR Ebrahimkhani, N Kipniss, JJ Velazquez, E Schoenfeld, ...
Nature communications 7 (1), 10243, 2016
1642016
Bioreactor technologies to support liver function in vitro
MR Ebrahimkhani, JAS Neiman, MSB Raredon, DJ Hughes, LG Griffith
Advanced drug delivery reviews 69, 132-157, 2014
1522014
Cross‐presentation of antigen by diverse subsets of murine liver cells
MR Ebrahimkhani, I Mohar, IN Crispe
Hepatology 54 (4), 1379-1387, 2011
1162011
Naltrexone, an opioid receptor antagonist, attenuates liver fibrosis in bile duct ligated rats
MR Ebrahimkhani, S Kiani, F Oakley, T Kendall, A Shariftabrizi, ...
Gut 55 (11), 1606-1616, 2006
992006
Metabolite profiling and pharmacokinetic evaluation of hydrocortisone in a perfused three-dimensional human liver bioreactor
U Sarkar, D Rivera-Burgos, EM Large, DJ Hughes, KC Ravindra, RL Dyer, ...
Drug metabolism and disposition 43 (7), 1091-1099, 2015
882015
Effect of morphine on ischemia-reperfusion injury: experimental study in testicular torsion rat model
AH Salmasi, A Beheshtian, S Payabvash, S Demehri, MR Ebrahimkhani, ...
Urology 66 (6), 1338-1342, 2005
752005
Human biomimetic liver microphysiology systems in drug development and precision medicine
A Gough, A Soto-Gutierrez, L Vernetti, MR Ebrahimkhani, AM Stern, ...
Nature Reviews Gastroenterology & Hepatology 18 (4), 252-268, 2021
702021
The c‐Rel subunit of nuclear factor‐κB regulates murine liver inflammation, wound‐healing, and hepatocyte proliferation
RG Gieling, AM Elsharkawy, JH Caamao, DE Cowie, MC Wright, ...
Hepatology 51 (3), 922-931, 2010
692010
Gene regulatory network analysis and engineering directs development and vascularization of multilineage human liver organoids
JJ Velazquez, R LeGraw, F Moghadam, Y Tan, J Kilbourne, JC Maggiore, ...
Cell systems 12 (1), 41-55. e11, 2021
682021
Isolation of non-parenchymal cells from the mouse liver
I Mohar, KJ Brempelis, SA Murray, MR Ebrahimkhani, IN Crispe
Malaria Vaccines: Methods and Protocols, 3-17, 2015
662015
Nitric oxide: a new concept in chronic sinusitis pathogenesis
M Naraghi, AF Deroee, MR Ebrahimkhani, S Kiani, AR Dehpour
American journal of otolaryngology 28 (5), 334-337, 2007
662007
Galactosylated LDL nanoparticles: a novel targeting delivery system to deliver antigen to macrophages and enhance antigen specific T cell responses
F Wu, SA Wuensch, M Azadniv, MR Ebrahimkhani, IN Crispe
Molecular pharmaceutics 6 (5), 1506-1517, 2009
542009
Hydrogen sulphide and the hyperdynamic circulation in cirrhosis: a hypothesis
MR Ebrahimkhani, AR Mani, K Moore
Gut 54 (12), 1668-1671, 2005
542005
Aag-initiated base excision repair promotes ischemia reperfusion injury in liver, brain, and kidney
MR Ebrahimkhani, A Daneshmand, A Mazumder, M Allocca, JA Calvo, ...
Proceedings of the National Academy of Sciences 111 (45), E4878-E4886, 2014
532014
CRISPR-based synthetic transcription factors in vivo: the future of therapeutic cellular programming
M Pandelakis, E Delgado, MR Ebrahimkhani
Cell systems 10 (1), 1-14, 2020
522020
Il sistema al momento non pu eseguire l'operazione. Riprova pi tardi.
Articoli 1–20